A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis
- 1 April 1994
- journal article
- clinical trial
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 9 (2) , 162-168
- https://doi.org/10.1111/j.1440-1746.1994.tb01237.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Differential Effects of Chenodeoxycholic and Ursodeoxycholic Acids on Interleukin 1, Interleukin 6 and Tumor Necrosis Factor-α Production by MonocytesHepatology, 1992
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992
- Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytesHepatology, 1991
- Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to IIIJournal of Hepatology, 1990
- Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liverJournal of Hepatology, 1990
- Failure of Rifampin to Relieve Pruritus in Chronic Liver DiseaseJournal of Clinical Gastroenterology, 1990
- Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosisHepatology, 1989
- Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosisHepatology, 1988
- A Prospective Trial of Colchicine for Primary Biliary CirrhosisNew England Journal of Medicine, 1986
- Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytesDigestive Diseases and Sciences, 1984